Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    China Pharma Inc.

    AMEX: CPHI · Real-Time Price · USD
    1.85
    0.11 (6.57%)
    At close: Jun 27, 2025, 3:59 PM
    1.76
    -4.86%
    After-hours: Jun 27, 2025, 05:52 PM EDT

    China Pharma Statistics

    Share Statistics

    China Pharma has 3.26M shares outstanding. The number of shares has increased by 0.01% in one year.

    Shares Outstanding

    n/a
    		 3.26M

    Shares Change (YoY)

    n/a
    		 0.01%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 17.09%

    Shares Floating

    n/a
    		 2.27M

    Failed to Deliver (FTD) Shares

    n/a
    		 782

    FTD / Avg. Volume

    n/a
    		 0.7%

    Short Selling Information

    The latest short interest is 44.63K, so 1.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 44.63K

    Short % of Shares Out

    n/a
    		 1.37%

    Short % of Float

    n/a
    		 1.52%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -8.59 and the forward PE ratio is null. China Pharma's PEG ratio is 0.12.

    PE Ratio

    n/a
    		 -8.59

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 8.98

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 5.13

    P/FCF Ratio

    n/a
    		 -53.68

    PEG Ratio

    n/a
    		 0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for China Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.65, with a Debt / Equity ratio of 0.45.

    Current Ratio

    n/a
    		 0.65

    Quick Ratio

    n/a
    		 0.2

    Debt / Equity

    n/a
    		 0.45

    Debt / EBITDA

    n/a
    		 -1.83

    Debt / FCF

    n/a
    		 -4.74

    Interest Coverage

    n/a
    		 -29.77

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $20,218.43

    Profits Per Employee

    n/a
    		 $-21,144.49

    Employee Count

    n/a
    		 224

    Asset Turnover

    n/a
    		 0.3

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -31.54% in the last 52 weeks. The beta is 0.75, so China Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.75

    52-Week Price Change

    n/a
    		 -31.54%

    50-Day Moving Average

    n/a
    		 1.85

    200-Day Moving Average

    n/a
    		 2.1

    Relative Strength Index (RSI)

    n/a
    		 48.57

    Average Volume (20 Days)

    n/a
    		 112,379

    Income Statement

    In the last 12 months, China Pharma had revenue of 4.53M and earned -4.74M in profits. Earnings per share was -0.27.

    Revenue

    n/a
    		 4.53M

    Gross Profit

    n/a
    		 -1.99M

    Operating Income

    n/a
    		 -4.59M

    Net Income

    n/a
    		 -4.74M

    EBITDA

    n/a
    		 -1.96M

    EBIT

    n/a
    		 -4.58M

    Earnings Per Share (EPS)

    n/a
    		 -0.27
    Full Income Statement

    Balance Sheet

    The company has 626.88K in cash and 3.59M in debt, giving a net cash position of -2.96M.

    Cash & Cash Equivalents

    n/a
    		 626.88K

    Total Debt

    n/a
    		 3.59M

    Net Cash

    n/a
    		 -2.96M

    Retained Earnings

    n/a
    		 -44.03M

    Total Assets

    n/a
    		 14,217.1B

    Working Capital

    n/a
    		 -2,271B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -466.36K and capital expenditures -291.72K, giving a free cash flow of -758.08K.

    Operating Cash Flow

    n/a
    		 -466.36K

    Capital Expenditures

    n/a
    		 -291.72K

    Free Cash Flow

    n/a
    		 -758.08K

    FCF Per Share

    n/a
    		 -0.04
    Full Cash Flow Statement

    Margins

    Gross margin is -43.84%, with operating and profit margins of -101.32% and -104.58%.

    Gross Margin

    n/a
    		 -43.84%

    Operating Margin

    n/a
    		 -101.32%

    Pretax Margin

    n/a
    		 -104.58%

    Profit Margin

    n/a
    		 -104.58%

    EBITDA Margin

    n/a
    		 -43.37%

    EBIT Margin

    n/a
    		 -101.32%

    FCF Margin

    n/a
    		 -16.74%

    Dividends & Yields

    CPHI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CPHI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 15, 2025. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Apr 15, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -4.7

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist